AI System Beats Scientist at Finding Repurposed Liver Fibrosis Drugs

Stanford's Gary Peltz tested his own drug picks against AI system Co-Scientist's. His two picks failed; two of the AI's three worked, with vorinostat blocking 91% of scarring response.